Table 4.
Relative risk for META comparing DOISNORE50 group with nonscreened group using propensity score matching.
| Comorbidity | Relative Risk (95% CI) |
|---|---|
| Hypercapnia | 3.69 (3.38–4.02) |
| AIDS | 1.45 (0.91–2.18) |
| CVA | 1.22 (1.08–1.36) |
| CHF | 1.64 (1.52–1.76) |
| Pulmonary disorder | 1.32 (1.23–1.41) |
| Afib | 1.49 (1.19–1.84) |
| COPD | 1.15 (1.05–1.26) |
| DM | 0.96 (0.88–1.03) |
| Malignancy | 1.90 (1.74–2.08) |
| Liver Disorder | 1.38 (1.16–1.63) |
| MI | 1.20 (1.09–1.33) |
Highest relative risk of META was noted among patients with hypercapnia, malignancy, and congestive heart failure. Afib = atrial fibrillation, AIDS = acquired immunodeficiency syndrome, CHF = congestive heart failure, CI = confidence interval, COPD = chronic obstructive pulmonary disease, CVA = cerebrovascular accident, DM = type 2 diabetes mellitus, META = medical emergency team activation, MI = myocardial infarction, RR = risk ratio.